-
Chief Medical Officer Resignation Will Not Affect Ultragenyx's Catalyst-Rich Timeline
Friday, June 17, 2016 - 3:27pm | 261Read More...After Thursday's close, Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) noted in its 8-k form about CMO Sunil Agarwal's resignation. The decision is effective August 18. The reason for the move was categorized as seeking a different career path. During the imminent search process for a new chief...
-
Ultragenyx Pharmaceutical Spikes 4% Following Release Of Positive Phase 2 Data
Thursday, April 21, 2016 - 12:28pm | 238Read More...Shares of Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) gained more than 4 percent on Thursday after company reported positive interim data from a Phase 2 study. Ultragenyx Pharmaceutical focuses on the development of novel products for rare and ultra-rare diseases. The company announced that...
